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Abstract 
Congenital disorders of glycosylation are a rare group of metabolic disorders that can result 
in multiorgan disease. This article describes a novel finding of macular hypoplasia in 
congenital disorders of glycosylation type Ia. 
 
Introduction 
Congenital disorders of glycosylation (CDG) are a rare group of metabolic disorders 
caused by defective synthesis of N-linked oligosaccharides [1]. These oligosaccharides 
have important biological functions, particularly in maintaining protein stability and 
facilitating cell-to-cell communication. 
CDG type Ia (CDG-Ia) is the most common type of CDG, and the clinical presentation 
of this disorder is highly variable, ranging from no involvement with normal 
development to significant neurological impairment with multisystem involvement [2] 
including ophthalmic manifestations. 
This article describes a case of macular hypoplasia associated with CDG-Ia. 
Case Report 
An 8-week-old female Caucasian infant was referred by a paediatrician for ocular assessment. She 
was born at 38 weeks’ gestation to non-consanguineous parents by spontaneous vaginal delivery 
following a normal pregnancy. She developed early feeding problems, which led to failure to thrive. 
She was also noted to have poor sucking, generalized hypotonia, mild hip dysplasia, stroke-like  
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episodes and significant gastro-oesophageal reflux with associated poor coordination of feeding. In 
addition, the infant had bilateral moderate to severe hearing loss. 
At 3 months of age, the infant’s transferrin isoform analysis demonstrated significantly elevated 
levels of disialo- and asialotransferrin. She also had low levels of antithrombin III, protein C and 
protein S as well as borderline hypothyroidism. TORCH panel involving testing for antibodies to 
Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex virus was negative. Magnetic 
resonance imaging of the brain showed ponto-cerebellar hypoplasia. Genetic analysis revealed that 
she was compound heterozygous for the p.R14H and p.G208A mutations in the phosphomannomutase 
2 (PMM2) gene, consistent with a diagnosis of CDG-Ia. 
On ocular examination, the infant appeared to demonstrate momentary awareness of but did not 
follow or fixate on light. She showed good doll’s eye movements and had frequent upturning of eyes 
but no nystagmus. Anterior ocular segment examination including slit-lamp examination was 
unremarkable, and in particular there were no signs of iris transillumination suggestive of albinism. 
Fundoscopy showed macular hypoplasia with blond retinal background (fig. 1). 
Follow-up ocular examination at 5 months of age continued to show persisting visual inattention, 
roving eye movements and bilateral macular hypoplasia. By 20 months of age, the patient was fixating 
and following well with each eye. Pendular nystagmus was noted, as was a 30-prism-dioptre left 
esotropia. Extra-ocular movements were full, and there were no signs of iris transillumination. 
Cycloplegic refraction was within normal limits (right eye +2.50 dioptres; left eye +2.50 dioptres). 
Fundus examination continued to show macular hypoplasia. 
Electrophysiological studies including cutaneous flash electroretinogram (ERG) were normal. 
Pattern-reversal ERG and visual-evoked cortical potentials were simultaneously recorded and 
demonstrated normal retinocortical time. 
Discussion 
CDG-Ia can result in multiorgan disease. In up to 70% of cases, it is associated with 
ocular abnormalities resulting in reduced visual acuity [3, 4]. The most common ocular 
feature is esotropia [4, 5]. This disorder has also been associated with progressive 
myopia, retinitis pigmentosa, optic neuropathy, optic disc hypoplasia, retinal coloboma, 
cone and rod dysfunction and bull’s eye maculopathy [3–6]. 
Although CDG-Ia has been associated with bull’s eye maculopathy [5], our case 
highlights that CDG-Ia may be also associated with macular hypoplasia. This association 
has not been previously described. 
The exact pathogenesis of macular hypoplasia in CDG-Ia is unknown, although it is 
likely to be related to the abnormal development of the retina and optic nerve that 
occurs in patients with CDG-Ia [5]. 
Given that ocular pathology may be the first indication of CDG-Ia [7], CDG-Ia should 
be considered when assessing patients with macular hypoplasia. Equally important, 
patients with CDG-Ia require a thorough ophthalmic examination. 
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Fig. 1. Fundus photographs of the right eye (a) and left eye (b) showing macular hypoplasia (white 
arrows) with blond retinal background and underlying choroidal vessels visible. 
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